The resulting impact on diet and nutrition means there is absolutely a growing opportunity in Europe for bespoke products for GLP-1 drug users, says Suketu Patel, global chief medical officer at Havas, which launched its own consultancy dedicated to GLP-1 innovation in June
Recent guidelines suggest considering surgery at lower BMI thresholds (30 kg/m) for patients with type 2 diabetes
[DOI] [PubMed] [Google Scholar] 874.Froehling D.A., Silverstein M.D., Mohr D.N., Beatty C.W., Offord K.P., Ballard D.J
Once youve begun taking a GLP-1, it can be easy to get wrapped up in weight lossbut Dr
[DOI] [PMC free article] [PubMed] [Google Scholar] 79.Fujisaka S., Usui I., Bukhari A., Ikutani M., Oya T., Kanatani Y., et al
Weighing risks and benefits of liraglutide--the FDAs review of a new antidiabetic therapy